Press Releases

    Print Page  Close Window
BioMed Realty Trust Revises Announcement of Tax Treatment of 2008 Distributions

SAN DIEGO, Jan. 30 /PRNewswire-FirstCall/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today amended its news release "BioMed Realty Trust Announces Tax Treatment of 2008 Distributions" issued January 20, 2009 with respect to the Taxable Ordinary Dividend and Return of Capital distributions for the four quarterly dividends displayed in the Common Stock table. The amended version of the distribution tables and information follows:


                        Security Description: Common Stock
                                CUSIP: 09063H107
                               Ticker Symbol: BMR

                                     Total                      Taxable
       Record       Payable      Distribution    Allocable      Ordinary
        Date          Date         Per Share      to 2008       Dividend
     12/31/2007    1/15/2008      $0.310000      $0.310000      $0.255350
     3/31/2008     4/15/2008      $0.335000      $0.335000      $0.275942
     6/30/2008     7/15/2008      $0.335000      $0.335000      $0.275942
     9/30/2008     10/15/2008     $0.335000      $0.335000      $0.275942
             Totals               $1.315000      $1.315000      $1.083176



                                                 Long-Term     Unrecaptured
       Record       Payable        Return of      Capital      Section 1250
        Date         Date          Capital         Gain            Gain
     12/31/2007    1/15/2008      $0.054650      $0.000000      $0.000000
     3/31/2008     4/15/2008      $0.059058      $0.000000      $0.000000
     6/30/2008     7/15/2008      $0.059058      $0.000000      $0.000000
     9/30/2008     10/15/2008     $0.059058      $0.000000      $0.000000
             Totals               $0.231824      $0.000000      $0.000000



                  Security Description: 7.375% Series A Cumulative
                             Redeemable Preferred Stock
                                 CUSIP: 09063H206
                              Ticker Symbol: BMR PR A

                                     Total                      Taxable
       Record       Payable      Distribution    Allocable      Ordinary
        Date          Date         Per Share      to 2008       Dividend
     12/31/2007    1/15/2008      $0.460940      $0.460940      $0.460940
     3/31/2008     4/15/2008      $0.460940      $0.460940      $0.460940
     6/30/2008     7/15/2008      $0.460940      $0.460940      $0.460940
     9/30/2008     10/15/2008     $0.460940      $0.460940      $0.460940
             Totals               $1.843760      $1.843760      $1.843760



                                                 Long-Term     Unrecaptured
       Record       Payable        Return of      Capital      Section 1250
        Date         Date          Capital         Gain            Gain
     12/31/2007   1/15/2008       $0.000000      $0.000000      $0.000000
     3/31/2008    4/15/2008       $0.000000      $0.000000      $0.000000
     6/30/2008    7/15/2008       $0.000000      $0.000000      $0.000000
     9/30/2008    10/15/2008      $0.000000      $0.000000      $0.000000
             Totals               $0.000000      $0.000000      $0.000000

The distributions payable on January 15, 2009 to shareholders of record on December 31, 2008, as previously announced on December 15, 2008, are considered 2009 distributions for federal income tax purposes.

The company did not incur any foreign taxes during 2008. In addition, only for purposes of calculating alternative minimum taxable income under Section 55 of the Internal Revenue Code of 1986, as amended, the company apportions $0.0009 per common share and Series A preferred share attributable to depreciation, each assuming a full year of ownership. Stockholders are encouraged to consult with their personal tax advisors as to their specific tax treatment of BioMed Realty Trust distributions.

About BioMed Realty Trust

BioMed Realty Trust, Inc. is a real estate investment trust (REIT) focused on Providing Real Estate to the Life Science Industry(R). The company's tenants primarily include biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. BioMed owns or has interests in 69 properties, representing 112 buildings with approximately 10.4 million rentable square feet, including approximately 1.4 million square feet of development in progress. The company also owns undeveloped land parcels adjacent to existing properties that it estimates can support up to 1.4 million rentable square feet. The company's properties are located predominantly in the major U.S. life science markets of Boston, San Diego, San Francisco, Seattle, Maryland, Pennsylvania and New York/New Jersey, which have well-established reputations as centers for scientific research. Additional information is available at www.biomedrealty.com.

SOURCE: BioMed Realty Trust, Inc.

CONTACT:
Rick Howe, Director, Corporate Communications of BioMed Realty Trust, Inc.,
+1-858-207-5859,
richard.howe@biomedrealty.com

Web Site: http://www.biomedrealty.com